✦ LIBER ✦

The risk of venous thromboembolism is markedly elevated in patients with diabetes

✍ Scribed by V. Petrauskiene; M. Falk; I. Waernbaum; M. Norberg; J. W. Eriksson

Publisher: Springer
Year: 2005
Tongue: English
Weight: 103 KB
Volume: 48
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-005-1715-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venous thromboembolism risk among hospit

Venous thromboembolism risk among hospitalized patients: Magnitude of the risk is staggering

✍ Samuel Z. Goldhaber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Risk of venous thromboembolism in hospit

Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters

✍ Bob L. Lobo; Georgeta Vaidean; Joyce Broyles; Anne B. Reaves; Ronald I. Shorr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract ## BACKGROUND: Peripherally inserted central catheters (PICC) are increasingly used in hospitalized patients. The benefit can be offset by complications such as upper extremity deep vein thrombosis (UEDVT). ## METHODS: Retrospective study of patients who received a PICC while hospita

ABO blood group is a potent risk factor

ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas

✍ Michael B. Streiff; Jodi Segal; Stuart A. Grossman; Thomas S. Kickler; Edward G. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with malignant gliomas. To investigate the pathogenesis of VTE and facilitate targeted prophylaxis strategies, the authors aimed to characterize VTE risk factors in these patients. #

Venous thromboembolism in the management

Venous thromboembolism in the management of patients with musculoskeletal tumor

✍ Takeshi Morii; Kazuo Mochizuki; Takashi Tajima; Takayuki Aoyagi; Kazuhiko Satomi 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 136 KB

The optimal duration of secondary thromb

The optimal duration of secondary thromboprophylaxis in patients with venous thromboembolism

✍ Paul Alexander Kyrle 📂 Article 📅 2005 🏛 Springer Vienna 🌐 German ⚖ 88 KB

Anticoagulation for the initial treatmen

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer : A systematic review

✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology